0.802
0.00 (0.10%)
| Penutupan Terdahulu | 0.801 |
| Buka | 0.820 |
| Jumlah Dagangan | 40,270 |
| Purata Dagangan (3B) | 182,541 |
| Modal Pasaran | 12,492,615 |
| Harga / Jualan (P/S) | 0.440 |
| Harga / Buku (P/B) | 5.44 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 15 May 2024 |
| Margin Keuntungan | -110.55% |
| Margin Operasi (TTM) | -141.73% |
| EPS Cair (TTM) | -0.710 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -23.00% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 92.48% |
| Nisbah Semasa (MRQ) | 0.550 |
| Aliran Tunai Operasi (OCF TTM) | -6.56 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -2.98 M |
| Pulangan Atas Aset (ROA TTM) | -88.58% |
| Pulangan Atas Ekuiti (ROE TTM) | -290.85% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Diagnostics & Research (US) | Menurun | Menurun |
| Diagnostics & Research (Global) | Menurun | Menurun | |
| Stok | bioAffinity Technologies, Inc. | Bercampur | - |
AISkor Stockmoo
| Konsensus Penganalisis | -2.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -0.5 |
| Purata | -1.13 |
|
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company’s product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer. |
|
| Sektor | Healthcare |
| Industri | Diagnostics & Research |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 24.53% |
| % Dimiliki oleh Institusi | 1.80% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |